These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 33251)

  • 1. Influence of pimozide on the locomotor hyperactivity produced by caffeine.
    Estler CJ
    J Pharm Pharmacol; 1979 Feb; 31(2):126-7. PubMed ID: 33251
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of phenoxybenzamine and pimozide to diminish changes in oxygen consumption and body temperature produced by caffeine.
    Estler CJ
    Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):326-30. PubMed ID: 485730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization by caffeine of central catecholamine receptors.
    Waldeck B
    J Neural Transm; 1973; 34(1):61-72. PubMed ID: 4714594
    [No Abstract]   [Full Text] [Related]  

  • 4. Extract of Hypericum perforatum blocks caffeine-induced locomotor activity in mice: a possible role of nitric oxide.
    Uzbay IT; Coskun I; Kayir H; Ozturk N; Ozturk Y
    Phytother Res; 2007 May; 21(5):415-9. PubMed ID: 17236177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of L-dopa and (+)-amphetamine on the locomotor activity after pimozide and phenoxybenzamine.
    Maj J; Sowinska H; Kapturkiewicz Z; Sarnak J
    J Pharm Pharmacol; 1972 May; 24(5):412-4. PubMed ID: 4403816
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of caffeine on locomotor activity and central catecholamine mechanisms: a study with special reference to drug interaction.
    Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 4):1-23. PubMed ID: 1080339
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of pimozide and phenoxybenzamine on the motor hyperactivity of rats treated with nialamide and dopamine (author's transl)].
    Malec D; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1975; 30():109-12. PubMed ID: 1230064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Caffeine-antagonistic effects of theobromine and caffeine-like properties of theobromine metabolites].
    Heim F; Hach B; Mitznegg P; Ammon HP; Estler CJ
    Arzneimittelforschung; 1971 Jul; 21(7):1039-43. PubMed ID: 5109494
    [No Abstract]   [Full Text] [Related]  

  • 9. Blockade by pimozide of (+)-amphetamine-induced hyperkinesia in mice.
    Schlechter JM; Butcher LL
    J Pharm Pharmacol; 1972 May; 24(5):408-9. PubMed ID: 4403814
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the pharmacological properties of sultopride sulpiride and other antipsychotic drugs: influence of sultopride, sulpiride and other antipsychotic drugs on spontaneous locomotor activity and changes in locomotor activity induced by apomorphine and clonidine in mice].
    Horikomi K; Fujita M
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):339-52. PubMed ID: 2880435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal by a central antiacetylcholine drug of pimozide-induced inhibition of mouse-jumping in amphetamine-dopa treated mice.
    Colpaert FC; Wauquier A; Niemegeers C; Lal H
    J Pharm Pharmacol; 1975 Jul; 27(7):536-7. PubMed ID: 239163
    [No Abstract]   [Full Text] [Related]  

  • 12. Caffeine interferes with morphine-induced hyperactivity but not analgesia.
    Oliverio A; Castellano C; Pavone F; Vetulani J
    Pol J Pharmacol Pharm; 1983; 35(6):445-9. PubMed ID: 6677894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of albumin degradation products (ADP) on the central action of caffeine.
    Buczko W; Tarasiewicz S
    Acta Med Pol; 1976; 17(2):111-7. PubMed ID: 937062
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of alpha-methyltryptamine on spontaneous activity in mice.
    Rusterholz DB; Long JP; Nichols DE
    Pharmacol Biochem Behav; 1979 Feb; 10(2):223-7. PubMed ID: 156369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central action of narcotic analgesics. Part III. The role of endogenous noradrenaline in hyperactivity induced by morphine or fentanyl in mice.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1978; 30(4):537-47. PubMed ID: 216979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of caffeine-induced locomotor hyperactivity produced by the combination with L-arginine or taurine in mice: Possible involvement of nitric oxide.
    Kimura M; Ushijima I; Hiraki M; Kimura M; Ono N
    Methods Find Exp Clin Pharmacol; 2009 Nov; 31(9):585-9. PubMed ID: 20094641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of amphetamine and nomifensine on the development of morphine tolerance in the test of hypermotility in mice and catalepsy in rats.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1983; 35(6):503-10. PubMed ID: 6687158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of LSD on locomotor activity in reserpinized mice.
    Grabowska M; Antikiewicz L; Michaluk J
    Pol J Pharmacol Pharm; 1974; 26(5):499-504. PubMed ID: 4427810
    [No Abstract]   [Full Text] [Related]  

  • 19. Alteration of exploration and the response to food associated cues after treatment with pimozide.
    Irwin J; Tombaugh TN; Zacharko RM; Anisman H
    Pharmacol Biochem Behav; 1983 Feb; 18(2):235-46. PubMed ID: 6835981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.